-+ 0.00%
-+ 0.00%
-+ 0.00%

Hanx Biopharma files HKEX next-day return disclosing share buyback at HKD 28.96 each

PUBT·07/10/2026 11:19:38
Listen to the news
Hanx Biopharma files HKEX next-day return disclosing share buyback at HKD 28.96 each
  • Hanx Biopharmaceuticals repurchased 41,400 H shares on July 10, 2026 for treasury, not cancellation.
  • Buyback price range HKD 28.4 to HKD 30 per share; total consideration HKD 1.2 million.
  • Treasury shares rose to 1,922,400; issued shares excluding treasury fell to 134,296,430.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals (Wuhan) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260710-12241471), on July 10, 2026, and is solely responsible for the information contained therein.